Hims & Hers Health (HIMS) FCF Margin Growth (3y) (2023 - 2026)

Hims & Hers Health (HIMS) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 253.00
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -1,444.00
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1,941.00
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4,671.00
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 1,067.00
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -42,016.00
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 895.00
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 830.00
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn 22,587.00

Historic Data

Download Data
DateValue
Mar 31, 2026 895.00
Dec 31, 2025 1,322.00
Sep 30, 2025 2,152.00
Jun 30, 2025 811.00
Mar 31, 2025 2,951.00
Dec 31, 2024 1,897.00
Sep 30, 2024 4,279.00
Jun 30, 2024 1,846.00
Mar 31, 2024 3,997.00
Dec 31, 2023 1,017.00
Sep 30, 2023 -93.00
Jun 30, 2023 886.00
Mar 31, 2023 2,307.00